Dr. Elliot Mitmaker

Academic title(s): 

Associate Professor of Surgery, McGill University

Associate Professor of Oncology, McGill University


Dr. Elliot Mitmaker
Contact Information
514-934-1934, ext 44337
Email address: 
elliot.mitmaker [at] mcgill.ca

MD, Jefferson Medical College, Philadelphia, PA; M.Sc. Experimental Surgery, McGill University; B.Sc. McGill University

Royal Victoria Hospital (RVH)
Hospital title: 
Endocrine Surgeon,
Director, Surgical Oncology Residency Training Program
General surgery
Selected publications: 

1: Mercier F, Laplace N, Mitmaker EJ, Colin C, Kraimps JL, Sebag F, Bourdy S,
Duclos A, Lifante JC; CATHY Study Group. Unexpected discrepancies in hospital
administrative databases can impact the accuracy of monitoring thyroid surgery
outcomes in France. PLoS One. 2018 Dec 6;13(12):e0208416. doi:
10.1371/journal.pone.0208416. eCollection 2018. PubMed PMID: 30521574; PubMed
Central PMCID: PMC6283582.

2: Mitmaker EJ, Tabah R, How J. Thyroid Nodule DNA Methylation Signatures: An
Important Diagnostic Annotation. Clin Cancer Res. 2018 Oct 16. doi:
10.1158/1078-0432.CCR-18-2820. [Epub ahead of print] PubMed PMID: 30327307.

3: Madani A, Gornitsky J, Watanabe Y, Benay C, Altieri MS, Pucher PH, Tabah R,
Mitmaker EJ. Measuring Decision-Making During Thyroidectomy: Validity Evidence
for a Web-Based Assessment Tool. World J Surg. 2018 Feb;42(2):376-383. doi:
10.1007/s00268-017-4322-y. PubMed PMID: 29110159.

4: Lee SS, Roche PJ, Giannopoulos PN, Mitmaker EJ, Tamilia M, Paliouras M,
Trifiro MA. Prostate-specific membrane antigen-directed nanoparticle targeting
for extreme nearfield ablation of prostate cancer cells. Tumour Biol. 2017
Mar;39(3):1010428317695943. doi: 10.1177/1010428317695943. PubMed PMID: 28351335.

5: Kluijfhout WP, Drake FT, Pasternak JD, Beninato T, Mitmaker EJ, Gosnell JE,
Shen WT, Suh I, Freise CE, Duh QY. De novo thyroid cancer following solid organ
transplantation-A 25-year experience at a high-volume institution with a review
of the literature. J Surg Oncol. 2017 Feb;115(2):105-108. doi: 10.1002/jso.24495.
Epub 2017 Jan 5. Review. PubMed PMID: 28054345.

6: Madani A, Watanabe Y, Bilgic E, Pucher PH, Vassiliou MC, Aggarwal R, Fried GM,
Mitmaker EJ, Feldman LS. Measuring intra-operative decision-making during
laparoscopic cholecystectomy: validity evidence for a novel interactive Web-based
assessment tool. Surg Endosc. 2017 Mar;31(3):1203-1212. doi:
10.1007/s00464-016-5091-7. Epub 2016 Jul 13. PubMed PMID: 27412125.

7: Dotan I, Roche PJ, Tamilia M, Paliouras M, Mitmaker EJ, Trifiro MA.
Correction: Engineering Multi-Walled Carbon Nanotube Therapeutic Bionanofluids to
Selectively Target Papillary Thyroid Cancer Cells. PLoS One. 2016 Jun
16;11(6):e0158022. doi: 10.1371/journal.pone.0158022. eCollection 2016. PubMed
PMID: 27309538; PubMed Central PMCID: PMC4911056.

8: Lodewijk L, Kluijfhout WP, Kist JW, Stegeman I, Plukker JT, Nieveen van Dijkum
EJ, Bonjer HJ, Bouvy ND, Schepers A, de Wilt JH, Netea-Maier RT, van der Hage JA,
Burger JW, Ho G, Lee WS, Shen WT, Aronova A, Zarnegar R, Benay C, Mitmaker EJ,
Sywak MS, Aniss AM, Kruijff S, James B, Grogan RH, Brunaud L, Hoch G, Pandolfi C,
Ruan DT, Jones MD, Guerrero MA, Valk GD, Borel Rinkes IH, Vriens MR.
Characteristics of contralateral carcinomas in patients with differentiated
thyroid cancer larger than 1 cm. Langenbecks Arch Surg. 2016 May;401(3):365-73.
doi: 10.1007/s00423-016-1393-4. Epub 2016 Mar 24. PubMed PMID: 27013326; PubMed
Central PMCID: PMC4851685.

9: Dotan I, Roche PJ, Paliouras M, Mitmaker EJ, Trifiro MA. Engineering
Multi-Walled Carbon Nanotube Therapeutic Bionanofluids to Selectively Target
Papillary Thyroid Cancer Cells. PLoS One. 2016 Feb 22;11(2):e0149723. doi:
10.1371/journal.pone.0149723. eCollection 2016. Erratum in: PLoS One.
2016;11(6):e0158022. PubMed PMID: 26901566; PubMed Central PMCID: PMC4762941.

10: Lee L, Mitmaker EJ, Chabot JA, Lee JA, Kuo JH. Cost-Effectiveness of
Diagnostic Lobectomy Versus Observation for Thyroid Nodules >4 cm. Thyroid. 2016
Feb;26(2):271-9. doi: 10.1089/thy.2015.0300. Epub 2016 Jan 22. PubMed PMID:


View more

Areas of interest: 

molecular mechanisms of endocrine malignancies of the thyroid, parathyroid and adrenal glands

Clinical Interests: 

minimally invasive endocrine surgery (thyroid, parathyroid, adrenal)

Back to top